Strikingly, the additional decrease in Cav3.1 expression in AD patients characterizes Cav3.1 (CACNA1G) as a critical factor of Ca2+ homeostasis and facilitates cognitive impairment. This evidence concerns the gene CACNA1G and Cognitive impairment.